TheSouthernCross.com.au

Yingli Pharma Announces NMPA Approval of New Anti-cancer Drug Linperlisib

  • Written by The Southern Cross

The first highly selective PI3Kδ inhibitor in China

SHANGHAI, CHINA - Media OutReach - 9 November 2022 - Shanghai Yingli Pharmaceutical Co., Ltd. (the "Company" or "Yingli Pharma") is pleased to announce that linperlisib, trade name因他瑞®, a novel phosphoinositide 3-kinase delta (PI3Kδ) inhibitor, has been approved by the National Medical Products Administration (NMPA) of China on November 9 for the treatment of relapsed/refractory follicular lymphoma (R/R FL) in patients who have received 2 or more prior systemic therapies.

More Articles ...

  1. Johnson Electric reports results for the half year ended 30 September 2022
  2. Top UK university welcomes talented international students as demand for health and life sciences booms
  3. SATA CommHealth’s Osteoporosis and Fall Prevention Festival Returns with First In-Person Edition
  4. Amazon donates S$100,000 to local NPOs, Delivering Smiles to children in Singapore
  5. Federation for Self-financing Tertiary Education Catalyses Diversified Development of Students with Diploma of Applied Education Programme
  6. DYXnet is Rolling Out the Enterprise-grade Email Security Solution with Green Radar
  7. Inaugural Batch of Cambodian Watchmakers Graduate from Prince Horology Bringing Swiss Watchmaking Craftmanship to The Kingdom
  8. Shopee: The Future of E-Commerce with Malaysian Influencers
  9. The Brilliant 2022 International Trade Awards Are Unveiled
  10. Victory Securities granted by the SFC for the provision of the full spectrum of virtual asset dealing and advisory services
  11. Leading Asian football to NFT Shibo Entertainment Launches Exclusive Football Non-fungible Token
  12. Switzerland Focus on Fintech Innovation to Continue Charting the Future
  13. Tia Lee Deletes All Instagram Photos, Puts up Mysterious Square Grid on Instagram
  14. Fosun Attends Forum Themed "Promoting Macao as a Platform Connecting China and Portuguese-speaking Countries" at the CIIE
  15. Equities First Holdings News: Podcast Collaboration with The Economist Group on "Shelter from the storm: Investing in the Era of Uncertainty" Releases Episode Two, "Can China's economic slowdown create opportunities in Asia?"
  16. The Club x Tap & Go promote "Everyone’s NFT"
  17. Bybit Launches New Futures Grid Bot
  18. Renovators and OPPO, the Always-on Innovators
  19. Dorsett Wanchai Proud to be Appointed "the Official Hotel Partner" of the Long-awaited Hong Kong Squash Open 2022
  20. Aon Study Finds Hong Kong Employers Responding to Talent Crunch With Focus on Retirement Age and Benefits for Older Workers